Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Revenue

    Tag: revenue

    You Searched For "Revenue"
    Trivitron Healthcare aims over Rs 1000 crore revenue in FY22

    Trivitron Healthcare aims over Rs 1000 crore revenue in FY22

    Medical Dialogues Bureau21 Jan 2020 10:00 AM IST
    "We are looking at a revenue of over Rs 1,000 crore for the fiscal year 2022. It will be achieved through organic and inorganic growth," Trivitron...
    AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year

    AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year

    Medical Dialogues Bureau18 Aug 2019 9:36 AM IST
    A four-week supply of Humira, the world's best-selling medicine, has a list price of about $5,174, amounting to more than $60,000 for a year.U.S:...
    Piramal Enterprises Q1 profit rises 21 percent to Rs 461 crore

    Piramal Enterprises Q1 profit rises 21 percent to Rs 461 crore

    Medical Dialogues Bureau31 July 2019 9:00 AM IST
    Piramal Enterprises said its total loan book grew 20 per cent year-on-year to Rs 56,605 crore. The housing finance loan book, which constitutes 11 per...
    Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel

    Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel

    Medical Dialogues Bureau28 July 2019 9:17 AM IST
    Sales of Eliquis, which Bristol-Myers shares with Pfizer Inc (PFE.N), rose 24% to $2.04 billion, while Orencia sales rose 9% to $778 million, both...
    Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence

    Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence

    Meghna A Singhania29 May 2019 2:37 PM IST
    New Delhi: The billionaire entrepreneur, Dilip Shanghvi, founder of the 1983 established drug giant Sun Pharmaceuticals (Sun Pharma) is striving to...
    Sun Pharma Q4 profit falls by half to Rs 636 crore due to change in distribution strategy

    Sun Pharma Q4 profit falls by half to Rs 636 crore due to change in distribution strategy

    Garima29 May 2019 9:45 AM IST
    Sun Pharma said the net profit for the fourth quarter of FY2018-19 is not comparable with the year-ago period due to the one-time impact of...
    Medikabazaar to raise Rs 200 crore in Series B funding

    Medikabazaar to raise Rs 200 crore in Series B funding

    Garima29 May 2019 9:30 AM IST
    This is being done as part of the Medikabazaar's growth and expansion plans to clock in $100 million in revenues in the financial year 2019-20, he...
    Natco Pharma Q4 PAT plunges to Rs 120 crore

    Natco Pharma Q4 PAT plunges to Rs 120 crore

    Garima28 May 2019 9:45 AM IST
    The company's board has declared a third interim dividend of Rs 1.25 per equity share of Rs 2 each, resulting in a total dividend payout of Rs 6.25...
    Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report

    Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report

    Meghna A Singhania26 May 2019 6:13 PM IST
    Shanghvi estimates that Sun Pharma has invested about $1 billion in its patented-drug programme so far. He says growth in the Indian generics...
    Aster DM Healthcare to focus on Expansion in South, West India, to invest Rs 650 crore: Report

    Aster DM Healthcare to focus on Expansion in South, West India, to invest Rs 650 crore: Report

    Farhat Nasim21 Jan 2019 2:13 PM IST
    "Our idea is to focus only on tertiary care in cities and we are exploring new facilities in Mumbai, Pune and in Thiruvananthapuram, where we have...
    Pharma sector earnings to remain muted in Dec quarter: Edelweiss Securities

    Pharma sector earnings to remain muted in Dec quarter: Edelweiss Securities

    Ruby Khatun Khatun7 Jan 2018 10:00 AM IST
    New Delhi: Pharma sector's December quarter revenue is estimated to remain flat, while profits are likely to slip owing to decline in US businesses...
    Lincoln Pharma gets patent for anti-malarial drug in India

    Lincoln Pharma gets patent for anti-malarial drug in India

    Ruby Khatun Khatun20 Dec 2017 12:02 PM IST
    New Delhi: Lincoln Pharmaceuticals has been awarded a patent for an anti-malarial drug in India, the company said.The patent has been awarded by the...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok